Publications

• Mycobacterium tuberculosis Infections in Solid Organ Transplantation
  Subramanian, A. K., & Morris, M. I. (2013). Mycobacterium tuberculosis Infections in Solid Organ Transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 13, 68–76.
• Epidemiology, risk factors, and outcomes of Clostridium difficile infection in kidney transplant recipients
  Neofytos, D., Kobayashi, K., Alonso, C. D., Cady-Reh, J., Lepley, D., Harris, M., … Marr, K. (2013). Epidemiology, risk factors, and outcomes of Clostridium difficile infection in kidney transplant recipients. TRANSPLANT INFECTIOUS DISEASE, 15(2), 134–141.
• Outcomes of Kidney Transplantation in HIV-Infected Recipients
  Stock, P. G., Barin, B., Murphy, B., Hanto, D., Diego, J. M., Light, J., … Roland, M. E. (2010). Outcomes of Kidney Transplantation in HIV-Infected Recipients. NEW ENGLAND JOURNAL OF MEDICINE, 363(21), 2004–14.
• Recommended curriculum for subspecialty training in transplant infectious disease on behalf of the American Society of Transplantation Infectious Diseases Community of Practice Educational Initiatives Working Group Avery, R., CLAUSS, H., Danziger-Isakov, L., Davis, J., Doucette, K., van Duin, D., … Subramanian, A. (2010). Recommended curriculum for subspecialty training in transplant infectious disease on behalf of the American Society of Transplantation Infectious Diseases Community of Practice Educational Initiatives Working Group. TRANSPLANT INFECTIOUS DISEASE, 12(3), 190–194.
  
• MELD Score Is an Important Predictor of Pretransplantation Mortality in HIV-Infected Liver Transplant Candidates Subramanian, A., Sulkowski, M., Barin, B., Stablein, D., Curry, M., Nissen, N., … Ragni, M. (2010). MELD Score Is an Important Predictor of Pretransplantation Mortality in HIV-Infected Liver Transplant Candidates. GASTROENTEROLOGY, 138(1), 159–64.
  
• Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection Terrault, N. A., Roland, M. E., Schiano, T., Dove, L., Wong, M. T., Poordad, F., … Stock, P. G. (2012). Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. LIVER TRANSPLANTATION, 18(6), 716–726.
  
• Donor-derived organ transplant transmission of coccidioidomycosis Dierberg, K. L., Marr, K. A., Subramanian, A., Nace, H., Desai, N., Locke, J. E., … Neofytos, D. (2012). Donor-derived organ transplant transmission of coccidioidomycosis. TRANSPLANT INFECTIOUS DISEASE, 14(3), 300–304.
  
• Fungal infection presenting as giant cell tubulointerstitial nephritis in kidney allograft Bagnasco, S. M., Subramanian, A. K., & Desai, N. M. (2012). Fungal infection presenting as giant cell tubulointerstitial nephritis in kidney allograft. TRANSPLANT INFECTIOUS DISEASE, 14(3), 288–291.
  
• Tuberculosis in solid organ transplant candidates and recipients: current and future challenges. Subramanian, A. K. (2014). Tuberculosis in solid organ transplant candidates and recipients: current and future challenges. Current Opinion in Infectious Diseases, 27(4), 316–21.
  
• False-positive QuantiFERON TB-Gold test due to Mycobacterium gordonae Gajurel, K., & Subramanian, A. K. (2016). False-positive QuantiFERON TB-Gold test due to Mycobacterium gordonae. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 84(4), 315–17.
  
• False-positive hepatitis C virus serology after placement of a ventricular assistance device Durand, C. M., Marr, K. A., OSTRANDER, D., Subramanian, A., Valsamakis, A., Cox, A., & Neofytos, D. (2016). False-positive hepatitis C virus serology after placement of a ventricular assistance device. TRANSPLANT INFECTIOUS DISEASE, 18(1), 146–49.
  
• Cutaneous zygomycosis (mucormycosis) Carpenter, C. F., & Subramanian, A. K. (1999). Cutaneous zygomycosis (mucormycosis). NEW ENGLAND JOURNAL OF MEDICINE, 341(25), 1891–91.
  
• Renal Transplant in HIV-Positive Patients Long-term Outcomes and Risk Factors for Graft Loss Locke, J. E., Montgomery, R. A., Warren, D. S., Subramanian, A., & Segev, D. L. (2009). Renal Transplant in HIV-Positive Patients Long-term Outcomes and Risk Factors for Graft Loss. ARCHIVES OF SURGERY, 144(1), 83–86.
  
• Provider Response to a Rare but Highly Publicized Transmission of HIV Through Solid Organ Transplantation Kucirka, L. M., Ros, L., Subramanian, A. K., Montgomery, R. A., & Segev, D. L. (2011). Provider Response to a Rare but Highly Publicized Transmission of HIV Through Solid Organ Transplantation. ARCHIVES OF SURGERY, 146(1), 41–45.
  
• The high-risk donor: viral infections in solid organ transplantation Singer, A. L., Kucirka, L. M., Namuyinga, R., Hanrahan, C., Subramanian, A. K., & Segev, D. L. (2008). The high-risk donor: viral infections in solid organ transplantation. CURRENT OPINION IN ORGAN TRANSPLANTATION, 13(4), 400–404.
  
• Correlation of Chlamydia pneumoniae infection and severity of accelerated graft arteriosclerosis after cardiac transplantation Subramanian, A. K., Quinn, T. C., Kickler, T. S., Kasper, E. K., & Tucker, P. C. (2002). Correlation of Chlamydia pneumoniae infection and severity of accelerated graft arteriosclerosis after cardiac transplantation. TRANSPLANTATION, 73(5), 761–64.
  
• Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation Hoffmann, C. J., Subramanian, A. K., Cameron, A. M., & Engels, E. A. (2008). Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation. TRANSPLANTATION, 86(6), 784–90.
  
• Nontuberculous Mycobacteria in Solid Organ Transplant Recipients Dorman, S., & Subramanian, A. (2009). Nontuberculous Mycobacteria in Solid Organ Transplant Recipients. AMERICAN JOURNAL OF TRANSPLANTATION, 9, S63–S69.
  
• Antimicrobial prophylaxis regimens following transplantation Subramanian, A. K. (2011). Antimicrobial prophylaxis regimens following transplantation. CURRENT OPINION IN INFECTIOUS DISEASES, 24(4), 344–49.
  
• Mycobacterium tuberculosis in Solid Organ Transplant Recipients Subramanian, A., & Dorman, S. (2009). Mycobacterium tuberculosis in Solid Organ Transplant Recipients. AMERICAN JOURNAL OF TRANSPLANTATION, 9, S57–S62.
  
• Actinomucor elegans as an Emerging Cause of Mucormycosis Mahmud, A., Lee, R., Munfus-McCray, D., Kwiatkowski, N., Subramanian, A., Neofytos, D., … Zhang, S. X. (2012). Actinomucor elegans as an Emerging Cause of Mucormycosis. JOURNAL OF CLINICAL MICROBIOLOGY, 50(3), 1092–95.
  
• Images in clinical medicine. Cutaneous zygomycosis (Mucormycosis). Carpenter, C. F., & Subramanian, A. K. (1999). Images in clinical medicine. Cutaneous zygomycosis (Mucormycosis). New England Journal of Medicine, 341(25), 1891-?
  
• West Nile virus encephalitis in a kidney transplant recipient Shepherd, J. C., Subramanian, A., Montgomery, R. A., Samaniego, M. D., Gong, G., Bergmann, A., … Dropulic, L. (2004). West Nile virus encephalitis in a kidney transplant recipient. AMERICAN JOURNAL OF TRANSPLANTATION, 4(5), 830–33.
  
• Should a prisoner be placed on the organ transplant waiting list? Cameron, A. M., Subramanian, A. K., Sulkowski, M. S., Thomas, D. L., & Nelson, K. E. (2008). Should a prisoner be placed on the organ transplant waiting list? The Virtual Mentor : VM, 10(2), 88–91.
  
• Detection and treatment of Strongyloides hyperinfection syndrome following lung transplantation Balagopal, A., Mills, L., Shah, A., & Subramanian, A. (2009). Detection and treatment of Strongyloides hyperinfection syndrome following lung transplantation. TRANSPLANT INFECTIOUS DISEASE, 11(2), 149–54.
  
• Use of Alternative Agents for Prevention of Opportunistic Infections in Heart and Lung Transplant Recipients. Epstein, D. J., Benamu, E., & Subramanian, A. (2018). Use of Alternative Agents for Prevention of Opportunistic Infections in Heart and Lung Transplant Recipients. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America.
  
• Tolerability of Fluoroquinolones in Management of Latent Tuberculosis in Liver Transplant Candidates Tien, V., Robilotti, E., Callister, D., Subramanian, A., Lutchman, G., & Ho, D. Y. (2015). Tolerability of Fluoroquinolones in Management of Latent Tuberculosis in Liver Transplant Candidates. CLINICAL INFECTIOUS DISEASES, 61(10), 1631–U154.
  
• Tuberculosis Recommendations for Solid Organ Transplant Recipients and Donors Santoro-Lopes, G., Subramanian, A. K., Molina, I., Maria Aguado, J., Rabagliatti, R., & Len, O. (2018). Tuberculosis Recommendations for Solid Organ Transplant Recipients and Donors. TRANSPLANTATION, 102(2), S60–S65.
  
• Prevention and Management of Tuberculosis in Solid Organ Transplant Recipients. Epstein, D. J., & Subramanian, A. K. (2018). Prevention and Management of Tuberculosis in Solid Organ Transplant Recipients. Infectious Disease Clinics of North America, 32(3), 703–18.
  
• Native Kidney Cytomegalovirus Nephritis and Cytomegalovirus Prostatitis in a Kidney Transplant Recipient. Tan, S. K., Cheng, X. S., Kao, C.-S., Weber, J., Pinsky, B. A., Gill, H. S., … Tan, J. C. (2018). Native Kidney Cytomegalovirus Nephritis and Cytomegalovirus Prostatitis in a Kidney Transplant Recipient. Transplant Infectious Disease : an Official Journal of the Transplantation Society, e12998.
  
• Infections in Transplant and Oncology Patients Preface Marr, K. A., & Subramanian, A. K. (2010). Infections in Transplant and Oncology Patients Preface. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 24(2), XIII-XV.
  
• Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls. Roland, M. E., Barin, B., Huprikar, S., Murphy, B., Hanto, D. W., Blumberg, E., … Stock, P. G. (2016). Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls. AIDS (London, England), 30(3), 435–44.
  
• Liver Transplantation for HCV Non-Viremic Recipients with HCV Viremic Donors. Kwong, A. J., Wall, A., Melcher, M., Wang, U., Ahmed, A., Subramanian, A., & Kwo, P. Y. (2018). Liver Transplantation for HCV Non-Viremic Recipients with HCV Viremic Donors. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
  
• Mycobacterium tuberculosis Infections in Solid Organ Transplantation: Guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation. Subramanian, A. K., & Theodoropoulos, N. M. (2019). Mycobacterium tuberculosis Infections in Solid Organ Transplantation: Guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation. Clinical Transplantation, e13513.
  
• Impact of Pre-Transplant Donor BK Viruria in Kidney Transplant Recipients. Tan, S. K., Huang, C. H., Sahoo, M. K., Weber, J., Kurzer, J., Stedman, M. R., … Pinsky, B. A. (2019). Impact of Pre-Transplant Donor BK Viruria in Kidney Transplant Recipients. The Journal of Infectious Diseases.
  
• Association of Antibiotic Resistance With Antibiotic Use for Epidermal Growth Factor Receptor Inhibitor-Related Papulopustular Eruption. Hirotsu, K., Dang, T. M., Li, S., Neal, J. W., Pugliese, S., Subramanian, A., & Kwong, B. Y. (2019). Association of Antibiotic Resistance With Antibiotic Use for Epidermal Growth Factor Receptor Inhibitor-Related Papulopustular Eruption. JAMA Dermatology.
  
• Use of Alternative Agents for Prevention of Opportunistic Infections in Heart and Lung Transplant Recipients Epstein, D. J., Benamu, E., & Subramanian, A. K. (2018). Use of Alternative Agents for Prevention of Opportunistic Infections in Heart and Lung Transplant Recipients. CLINICAL INFECTIOUS DISEASES, 67(10), 1637–39.
  
• Successful eradication of chronic symptomatic Candida krusei urinary tract infection with increased dose micafungin in a liver and kidney transplant recipient: case report and review of the literature. Multani, A., Subramanian, A. K., & Liu, A. Y. (2019). Successful eradication of chronic symptomatic Candida krusei urinary tract infection with increased dose micafungin in a liver and kidney transplant recipient: case report and review of the literature. Transplant Infectious Disease : an Official Journal of the Transplantation Society, e13118.
  
• Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors Kwong, A. J., Wall, A., Melcher, M., Wang, U., Ahmed, A., Subramanian, A., & Kwo, P. Y. (2019). Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors. AMERICAN JOURNAL OF TRANSPLANTATION, 19(5), 1380–87.
  
• Incidence of Active Tuberculosis Following Hematopoietic Cell Transplantation: A Small but Real Threat. Aronson, J. R., Rezvani, A. R., & Subramanian, A. (2019). Incidence of Active Tuberculosis Following Hematopoietic Cell Transplantation: A Small but Real Threat. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America.
  
• Impact of Pretransplant Donor BK Viruria in Kidney Transplant Recipients Tan, S. K., Huang, C. H., Sahoo, M. K., Weber, J., Kurzer, J., Stedman, M. R., … Pinsky, B. A. (2019). Impact of Pretransplant Donor BK Viruria in Kidney Transplant Recipients. JOURNAL OF INFECTIOUS DISEASES, 220(3), 370–76.
  
• Association of Antibiotic Resistance With Antibiotic Use for Epidermal Growth Factor Receptor Inhibitor-Related Papulopustular Eruption Hirotsu, K., Dang, T. M., Li, S., Neal, J. W., Pugliese, S., Subramanian, A., & Kwong, B. Y. (2019). Association of Antibiotic Resistance With Antibiotic Use for Epidermal Growth Factor Receptor Inhibitor-Related Papulopustular Eruption. JAMA DERMATOLOGY, 155(7), 848–50.
  
• Mycobacterium tuberculosis infections in solid organ transplantation: Guidelines from the infectious diseases community of practice of the American Society of Transplantation Subramanian, A. K., & Theodoropoulos, N. M. (2019). Mycobacterium tuberculosis infections in solid organ transplantation: Guidelines from the infectious diseases community of practice of the American Society of Transplantation. CLINICAL TRANSPLANTATION, 33(9).
  
• A Multicenter, Longitudinal Cohort Study of Cryptococcosis in Human Immunodeficiency Virus-negative People in the United States Marr, K. A., Sun, Y., Spec, A., Lu, N., Panackal, A., Bennett, J., … Powderly, W. (2020). A Multicenter, Longitudinal Cohort Study of Cryptococcosis in Human Immunodeficiency Virus-negative People in the United States. CLINICAL INFECTIOUS DISEASES, 70(2), 252–61.
  
• Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection. Webb, B. J., Subramanian, A., Lopansri, B., Goodman, B., Jones, P. B., Ferraro, J., … Brown, S. M. (2020). Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection. Antimicrobial Agents and Chemotherapy.
  
• Characteristics and outcomes of coronavirus disease patients under nonsurge conditions, northern California, USA, March–April 2020 Ferguson, J., Rosser, J., Quintero, O., Scott, J., Subramanian, A., Gumma, M., … Kappagoda, S. (2020). Characteristics and outcomes of coronavirus disease patients under nonsurge conditions, northern California, USA, March–April 2020. Emerging Infectious Diseases.
  
• Infections Related to Biologics. Ho, D. Y., & Subramanian, A. K. (2020). Infections Related to Biologics. Infectious Disease Clinics of North America, 34(2), xiii-xvi.
  
• Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. Goldman, J. D., Lye, D. C., Hui, D. S., Marks, K. M., Bruno, R., Montejano, R., … Subramanian, A. (2020). Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. The New England Journal of Medicine.
  
• A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Wilk, A. J., Rustagi, A., Zhao, N. Q., Roque, J., Martinez-Colon, G. J., McKechnie, J. L., … Blish, C. A. (2020). A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nature Medicine.
  
• Simultaneous Coccidioidomycosis and Phaeohyphomycosis in a Kidney Transplant Recipient: A Case Report and Literature Review. Puing, A. G., Couture-Cossette, A., Wang, A. X., Zygourakis, C. C., Cheng, X., Stevens, B. A., … Subramanian, A. (2020). Simultaneous Coccidioidomycosis and Phaeohyphomycosis in a Kidney Transplant Recipient: A Case Report and Literature Review. Transplant Infectious Disease : an Official Journal of the Transplantation Society, e13365.
  
• Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis. Wilson, J. G., Simpson, L. J., Ferreira, A.-M., Rustagi, A., Roque, J. A., Asuni, A., … Rogers, A. J. (2020). Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis. JCI Insight.
  
• Use of Remdesivir for Pregnant Patients with Severe Novel 2019 Coronavirus Disease. Igbinosa, I., Miller, S., Bianco, K., Nelson, J., Kappagoda, S., Blackburn, B. G., … Aziz, N. (2020). Use of Remdesivir for Pregnant Patients with Severe Novel 2019 Coronavirus Disease. American Journal of Obstetrics and Gynecology.
  
• Quantifying Infection Risks in Incompatible Living Donor Kidney Transplant Recipients. Avery, R. K., Motter, J. D., Jackson, K. R., Montgomery, R. A., Massie, A. B., Kraus, E. S., … Garonzik, J. M. (2020). Quantifying Infection Risks in Incompatible Living Donor Kidney Transplant Recipients. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
  
• IMPACT OF BASELINE ALANINE AMINOTRANSFERASE LEVELS ON THE SAFETY AND EFFICACY OF REMDESIVIR IN SEVERE COVID-19 PATIENTS Goldman, J. D., Lye, D. C. B., Hui, D. S.-C., Marks, K., Bruno, R., Montejano, R., … Subramanian, A. (2020). IMPACT OF BASELINE ALANINE AMINOTRANSFERASE LEVELS ON THE SAFETY AND EFFICACY OF REMDESIVIR IN SEVERE COVID-19 PATIENTS. HEPATOLOGY, 72, 279A.